ArticleFrontiers in endocrinology2025

Cemiplimab and diabetic ketoacidosis: a case report of a rare endocrinopathy associated with immune checkpoint inhibitors.

Anna Arecco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.